Hypertension

January 13, 2021

In this column, Dr. Paul Thompson offers his perspective on the use of digoxin and explains why he has maintained use in certain patient populations despite its waning popularity in recent years.

January 08, 2021

Results of the REPLACE COVID trial offer clinicians an opportunity to better understand the impact of discontinuing therapy with ACEs or ARBs.

December 21, 2020

A retrospective analysis of more than 7k patients from the ACCORD trial suggests intensive blood pressure and intensive blood glucose control could reduce the risk of cardiovascular autonomic neuropathy in diabetics.

December 14, 2020

An analysis of more than 7k patients from Brazil suggests high blood pressure at any age and for any amount of time was linked to accelerated cognitive decline later in life.

December 02, 2020

Data from more than 37k patients in the UK Biobank study suggests hypertension in midlife was linked to an increased risk of white matter hyperintensities later in life.

September 11, 2020

A study published in an AHA journal describes recent trends, predictors, and outcomes of stroke in patients with hypertensive disorders of pregnancy.

September 07, 2020

Dr. Gregory Weiss compiles thoughts and perspective on hot line trials presented at ESC Congress 2020.

September 01, 2020

Investigators found no benefit from the discontinuation of ACE inhibitors/ARBs in patients hospitalized with COVID-19 in a prospective, randomized, phase 4 trial.

August 31, 2020

The largest and most comprehensive look at blood pressure therapies and cardiovascular disease risk to date is providing an overview of the effects of antihypertensive therapy at varying levels of baseline blood pressure.

August 25, 2020

An analysis of more than 3 million Europeans receiving an antihypertensive medication indicates medications for high blood pressure were not linked to an increase in risk of depressive disorders.